Drugs / DKY709
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03891953 | May 2019 → Oct 2026 expected | colorectal cancer, melanoma, nasopharyngeal carcinoma, non-small cell lung carcinoma +1 | Novartis Pharmaceuticals | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DKY709 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03891953 ↗ |
| Known as | DYK709 | ChEMBL registry synonym — accepted as the source's own label CHEMBL5077506 ↗ |
| Known as | NVP-DKY709 | ChEMBL registry synonym — accepted as the source's own label CHEMBL5077506 ↗ |